| Business Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Advertising > To Be Creative-Be Brief |
|
Business Articles - To Be Creative-Be Brief
Creative people work best when they are given limitations. I know that sounds counterintuitive but is it true. These limitatio According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ns help your creative team members focus so that the message they develop will be relevant, impactful, original and true. So, ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in how do you provide these limitations to your creative team: with a creative brief. Let’s take a look at how you go about devel lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ping one. There are five basic areas of information you need to supply your creative team in order to get the best possible w here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe rk. First, is an overview that spells out what’s happening in the market and with the client. Additionally, you need to outlin d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro who the communication is addressing and what is the one thing we want to say to that target audience. Think of this area in t ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc rms of headlines. We’ll get more specific later in the brief. Next, what is the purpose of this communication. What do we wan easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi t our target audience to think, feel, or do after seeing the message? Do we want them to visit a website, call an 800 number, nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ell a friend? In the next section of the brief, we more clearly define who we are addressing. Delve as deeply as possible int and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ the demographics and psychographics of an audience. What drives them? Will this be a rational decision or an emotional one fo ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi this particular audience? What are their media habits? Where do they live and work? What do they read, watch, listen to, and ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a hich websites do they frequent? Detail is king in this section of the brief. Next, we outline the single most persuasive idea dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod we can convey. This should be a simple, highly specific sentence or two. This is hard work and is where most creative briefs f cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin il. You shouldn’t expect great creative if you can’t give your team this highly condensed information. Now we need to provide tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen the rest of the story. Is there evidence to support our single most important idea? This is where we layer on both rational a t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel d emotional reasons to believe what we have said. Are there other major copy points to help persuade our audience? What is the ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust client’s brand personality? This helps your team understand the tone the message should take. Then, relate all the details of y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products our offer, if there is one, as well as mandatory client information like logos, address, phone number, and web address. A fin . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de l word on developing great creative briefs: bring your brief to life with customer quotes, stories from the marketplace and re elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip earch. Once you’ve outlined the limits, your team can come back with communications that are on target, creative and effective tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Business Travel Made Easy By Businessperson Minded Hotels Fuel Saver Scammer Finally Caught Home Builders and Remodelers - Everyday Phrases that Make it HARDER for You to Sell Your Services
|